Price · as of 2025
$2.59
Market cap 457.46M
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | $0.78 | -70% |
| P/E | -20.61 | |
| P/B | 5.02 | |
| P/S | 1.56 | |
| EV/EBITDA | -60.97 | |
| PEG | — | |
| P/TBV | 5.12 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $3.73 | $14.69 | |||
| 2012 | $4.23 | $14.13 | |||
| 2013 | $6.11 | $12.09 | |||
| 2014 | $4.12 | $13.80 | |||
| 2015 | $5.65 | $13.25 | |||
| 2016 | $4.45 | $12.99 | |||
| 2017 | $4.87 | $13.66 | |||
| 2018 | $6.48 | $16.08 | |||
| 2019 | $5.49 | $13.21 | |||
| 2020 | $6.39 | $14.73 | |||
| 2021 | $5.22 | $15.54 | |||
| 2022 | $2.80 | $13.97 | |||
| 2023 | $2.26 | $12.68 | |||
| 2024 | $1.51 | $16.21 | |||
| 2025 | $1.69 | $14.83 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About Cerus Corporation
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell components. Furthermore, Cerus markets an INTERCEPT Blood System for Cryoprecipitation, which leverages its plasma technology to produce two key pathogen-reduced blood products: a cryoprecipitated fibrinogen complex for treating and controlling bleeding, particularly massive hemorrhages stemming from fibrinogen deficiency, and pathogen-reduced, cryoprecipitate-reduced plasma. Cerus distributes these platelet and plasma systems globally through a combination of its direct sales force and an extensive network of distributors, reaching markets in North America, Europe, the Commonwealth of Independent States, the Middle East, and Latin America. Established in 1991, Cerus Corporation maintains its corporate headquarters in Concord, California.
- CEO
- Vivek K. Jayaraman
- Employees
- 275
- Beta
- 1.77
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| CERS | Cerus Corporation | $2.59 | 457.46M | $14.83 | +473% | -20.61 | 5.02 | 1.56 | -60.97 | — | 5.12 | 54.47% | -4.21% | -7.58% | -25.97% | -11.42% | -7.39% | 1.51 | -1.04 | 1.73 | 1.12 | -13.96 | -25.45% | 14.35% | 0.00% | 2.65% | 0.11 | 11.21% | 0.00% | 0.00% | 0.26% | -38.72 | 39.45 | 1.63 | -4.39 |
| CVRX | CVRx, Inc. | $2.39 | 63.42M | $12.49 | +423% | -3.68 | 4.99 | 3.47 | -3.67 | — | 4.99 | 85.33% | -90.49% | -94.10% | -96.59% | -342.11% | -44.76% | 1.29 | -8.80 | 7.63 | 6.49 | 0.53 | -23.02% | 10.45% | 0.60% | -20.75% | -3.02 | -272.03% | 0.00% | 0.00% | 0.00% | -3.35 | -4.21 | 3.03 | -6.15 |
| MASS | 908 Devices Inc. | $8.88 | 364.32M | $24.71 | +178% | 11.28 | 1.53 | 3.91 | -4.28 | — | 2.05 | 47.68% | -43.03% | -65.20% | 15.09% | -48.74% | 11.15% | 0.12 | — | 4.24 | 3.65 | 3.33 | -125.47% | -5.76% | -20.12% | -11.21% | -0.70 | -49.77% | 0.00% | 0.00% | 26.76% | -5.11 | -5.01 | 2.20 | 1.77 |
| NPCE | NeuroPace, Inc. | $14.83 | 505.61M | $17.96 | +21% | -21.48 | 24.23 | 4.61 | -39.04 | — | 24.23 | 77.23% | -16.34% | -21.47% | -158.74% | -56.92% | -21.44% | 3.72 | -2.19 | 5.28 | 4.25 | -4.08 | -29.03% | 25.13% | -37.89% | -2.46% | -0.62 | -39.50% | 0.00% | 0.00% | 13.08% | -28.82 | -41.53 | 4.71 | -2.83 |
| QTRX | Quanterix Corporation | $4.03 | 189.84M | $7.05 | +75% | -1.88 | 0.68 | 1.45 | -1.29 | -1.24 | 1.46 | 46.67% | -79.20% | -77.28% | -34.25% | -71.53% | -25.97% | 0.13 | — | 2.84 | 1.98 | -0.08 | 151.00% | 2.38% | 107.23% | -39.67% | -1.03 | -54.50% | 0.00% | 0.00% | 0.00% | -1.10 | -1.51 | 0.87 | -1.09 |
| RXST | RxSight, Inc. | $6.26 | 259.14M | $12.95 | +107% | -7.75 | 1.09 | 2.24 | -2.18 | -22.93 | 1.09 | 76.60% | -35.84% | -28.96% | -13.99% | -83.88% | -12.36% | 0.04 | -1204.75 | 10.95 | 9.58 | 0.23 | 33.80% | -3.89% | -13.60% | -6.41% | -0.59 | -33.66% | 0.00% | 0.00% | 1.49% | -1.76 | -4.38 | 0.63 | 2.97 |
| SENS | Senseonics Holdings, Inc. | $7.02 | 293.39M | $13.79 | +96% | -3.41 | 3.86 | 6.68 | -2.92 | — | 3.91 | 44.71% | -193.83% | -196.03% | -310.68% | 629.54% | -60.97% | 0.68 | -13.80 | 4.83 | 4.37 | -0.01 | -33.60% | 56.89% | -3.92% | -25.60% | -2.43 | 555.00% | 0.00% | 0.00% | 0.00% | -2.67 | -3.03 | 5.18 | -9.73 |
| SGHT | Sight Sciences, Inc. | $7.47 | 406.44M | $12.78 | +71% | -4.98 | 2.99 | 2.47 | -4.28 | — | 2.99 | 86.17% | -47.95% | -49.67% | -50.74% | -365.87% | -29.77% | 0.64 | -7.21 | 10.22 | 9.22 | 1.56 | -28.16% | -3.13% | 31.59% | -15.63% | -2.69 | -295.05% | 0.00% | 0.00% | 0.00% | -3.78 | -4.69 | 1.81 | -1.77 |
| SNWV | SANUWAVE Health Inc. | $5.88 | 50.56M | $35.67 | +507% | 15.60 | 113.80 | 4.18 | 10.05 | — | -21.26 | 77.11% | 11.23% | 26.82% | -212.89% | 64.71% | 35.02% | 14.19 | 0.79 | 1.38 | 0.97 | 0.57 | -105.83% | 34.98% | -1.58% | 1.05% | 0.22 | 25.49% | 0.00% | 0.00% | 2.31% | 39.49 | 100.96 | 4.43 | -4.17 |
| TKNO | Alpha Teknova, Inc. | $6.46 | 346.35M | $13.76 | +113% | -8.65 | 2.17 | 3.68 | -15.61 | — | 2.63 | 33.17% | -41.90% | -42.59% | -22.83% | -21.20% | -15.52% | 0.22 | -23.91 | 4.58 | 1.40 | -0.91 | -43.86% | 7.35% | -27.54% | -6.56% | -1.15 | -12.23% | 0.00% | 0.00% | 11.55% | -9.33 | -16.18 | 3.91 | 0.90 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.78 ÷ $2.59) − 1 = -69.88% (IC, example).